English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Genzyme Corporation
Carol Ostrow
| Sep 23, 2017
Study shows Dupixent reduces symptoms of atopic dermatitis
Carol Ostrow
| Sep 20, 2017
Sanofi partner Alnylam to suspend fitusiran trial for treating hemophilia
Nicholas Gueguen
| Aug 4, 2017
Sanofi Genzyme observes Rare Disease Day globally
Ruth de Jauregui
| May 7, 2017
Data from multiple sclerosis medication study shows promise
Ruth de Jauregui
| May 7, 2017
Sanfoli Genzyme releases 6 years of data on Lemtrada in patients with relapsing remitting multiple sclerosis
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
Ruth de Jauregui
| Mar 29, 2017
Multiple Myeloma Journey Partners Program to expand
Robert Lawson
| Feb 19, 2017
Trial focuses on common genetic link to Parkinson's
Trending
Patient Daily
| Sep 3, 2025
Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+
Pharmaceuticals
Patient Daily
| Sep 4, 2025
PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+
Pharmaceuticals
Patient Daily
| Aug 29, 2025
Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+
Pharmaceuticals
Patient Daily
| Sep 2, 2025
Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
